It was reported that alerts were generated for this system for cardiac resynchronization therapy pacing of less than 80%, anti-tachycardia pacing (atp) therapy delivered to convert an arrhythmia and ventricular shock therapy delivered to convert an arrhythmia.Episode review identified the therapy was potentially inappropriate for an atrial arrhythmia with rapid ventricular response (rvr).The rhythmmatch score was greater than 97%; however, the v>a criteria was met.The device was programmed to vvir with atrial sensing off and atrial tachycardia discrimination remains on.The clinical observations were documented, and the system remains in service.No adverse patient effects were reported.
|